Your browser doesn't support javascript.
loading
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer.
Elgendy, Mohamed; Fusco, Juan Pablo; Segura, Victor; Lozano, Maria Dolores; Minucci, Saverio; Echeveste, Jose Ignacio; Gurpide, Alfonso; Andueza, Mapi; Melero, Ignacio; Sanmamed, Miguel F; Ruiz, Maria Rodriguez; Calvo, Alfonso; Pascual, Juan Ignacio; Velis, Jose María; Miñana, Bernardino; Valle, Ricardo Diez; Pio, Ruben; Agorreta, Jackeline; Abengozar, Marta; Colecchia, Maurizio; Brich, Silvia; Renne, Salvatore Lorenzo; Guruceaga, Elisabet; Patiño-García, Ana; Perez-Gracia, Jose Luis.
Afiliación
  • Elgendy M; Department of Experimental Oncology, European Institute of Oncology (IEO), Milan, Italy.
  • Fusco JP; Department of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
  • Segura V; Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain.
  • Lozano MD; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.
  • Minucci S; Bioinformatics Unit, Center for Applied Medical Research (CIMA), IDISNA, University of Navarra, Pamplona, Spain.
  • Echeveste JI; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.
  • Gurpide A; Pathology Department, Clinica Universidad de Navarra, Pamplona, Spain.
  • Andueza M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain.
  • Melero I; Department of Experimental Oncology, European Institute of Oncology (IEO), Milan, Italy.
  • Sanmamed MF; Department of Biosciences, University of Milan, Milan, Italy.
  • Ruiz MR; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.
  • Calvo A; Pathology Department, Clinica Universidad de Navarra, Pamplona, Spain.
  • Pascual JI; Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain.
  • Velis JM; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.
  • Miñana B; Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain.
  • Valle RD; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.
  • Pio R; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.
  • Agorreta J; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain.
  • Abengozar M; Department of Immunology, Center for Applied Medical Research (CIMA), Pamplona, Spain.
  • Colecchia M; Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain.
  • Brich S; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.
  • Renne SL; Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain.
  • Guruceaga E; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.
  • Patiño-García A; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.
  • Perez-Gracia JL; Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Spain.
Int J Cancer ; 145(7): 1991-2001, 2019 10 01.
Article en En | MEDLINE | ID: mdl-30848481
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Biomarcadores de Tumor / Resistencia a Antineoplásicos / Neoplasias Renales / Mutación Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Biomarcadores de Tumor / Resistencia a Antineoplásicos / Neoplasias Renales / Mutación Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos